Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time

Key Takeaway: Lantheus Holdings, Inc. has announced a conference call and webcast scheduled for August 3, 2023, at 8:00 a.m. ET, to discuss its financial and operational results for the second quarter of 2023. The event aims to provide insights into the company’s performance and is accessible through an online registration process. A replay of the event will be available after the live broadcast for those unable to attend.
Price reaction · baseline $89.21 (2023-07-19 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
-4.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is set to share its second-quarter 2023 results, signaling proactive communication with investors.
  • The conference call provides an opportunity for transparency regarding financial performance.
  • Lantheus has a strong commitment to improving patient outcomes through advanced healthcare solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 3, 2023, to discuss its financial and operating results for the second quarter of 2023.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus Holdings' next conference call?

Lantheus Holdings will host a conference call on August 3, 2023, at 8:00 a.m. ET.

How can I access the Lantheus conference call?

Participants can register online at Lantheus' investor website to access the call.

Will there be a replay of the conference call?

Yes, a replay will be available about two hours after the call ends.

How long will the replay be available?

The replay will be archived for at least 30 days on the same webpage.

What is Lantheus Holdings' focus in healthcare?

Lantheus is dedicated to improving patient outcomes through diagnostics and AI solutions.

Last updated: Jul 20, 2023